Cooley: #1 in Life Sciences Venture Capital Financing

Palo Alto – February 2, 2016 – For the third year in a row, Cooley has been ranked the most active law firm in 2015 for life sciences venture financings according to data from VentureSource, Dow Jones's comprehensive global database on companies backed by venture capital and private equity.

"Cooley plays a pivotal role in the growth of many of the world's most promising life sciences companies," said Barbara Kosacz, partner and head of the firm's global life sciences group. "The depth and breadth of our industry knowledge allows us to add unique value for our clients across this dynamic sector."

The firm's international client base includes both public and private companies and spans a breadth of the life sciences sectors from therapeutics to drug delivery and formulation to medical technology.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Barbara Kosacz  Senior Counsel Palo Alto
Related Practices & Industries

Venture Capital  Life Sciences  Venture Capital